| Members |
targetComponentId |
| Telephoned report |
Telephoned report (record artifact) |
| Teleradiotherapy of unlisted particulate radiation |
External beam radiation therapy procedure |
| Teletherapy with radium collar |
Radium therapy (procedure) |
| Temperature of blood |
Core body temperature measured in blood (observable entity) |
| Temporary code for ultrastructural feature |
Subcellular structure |
| Temporary urinary catheter |
Urinary catheter |
| Temporomandibular joint X-ray |
Plain X-ray of temporomandibular joint (procedure) |
| Temsirolimus 25mg/mL injection solution vial + diluent |
Temsirolimus only product |
| Temsirolimus 25mg/mL powder for conventional release solution for injection vial |
Temsirolimus only product |
| Ten previous induced terminations of pregnancy |
Past pregnancy history of multiple induced termination of pregnancy |
| Tendon lengthening procedure |
Surgical lengthening - action |
| Tendon rupture NOS |
Traumatic rupture of tendon (disorder) |
| Tendon rupture NOS |
Traumatic rupture of tendon (disorder) |
| Tendon transfer procedure |
Surgical transfer - action |
| Tendoperiostitis |
Tenoperiostitis (disorder) |
| Tenecteplase 8000iu(40mg) powder and solvent for injection solution vial |
Product containing only tenecteplase (medicinal product) |
| Tenecteplase 8000iu(40mg) powder for conventional release solution for injection vial |
Product containing only tenecteplase (medicinal product) |
| Teniposide 10mg/mL injection solution 5mL vial |
Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Teniposide 50mg injection solution ampule |
Product containing precisely teniposide 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tenosynovitis of foot and ankle, NEC |
Tenosynovitis |
| Tenosynovitis of hand and wrist, NEC |
Tenosynovitis |
| Tenure - Dentine bonding agent |
Dentine bonding agent (substance) |
| Tenure of accommodation |
Tenure of accommodation |
| Teratoma - category |
Teratoma |
| Teratoma, malignant, no International Classification of Diseases for Oncology subtype |
Malignant teratoma (morphologic abnormality) |
| Teratoma, no International Classification of Diseases for Oncology subtype |
Teratoma of uncertain behavior (morphologic abnormality) |
| Terazosin hydrochloride 10mg |
Terazosin (as terazosin hydrochloride) 10 mg oral capsule |
| Terazosin hydrochloride 1mg |
Terazosin (as terazosin hydrochloride) 1 mg oral capsule |
| Terazosin hydrochloride 5mg |
Terazosin (as terazosin hydrochloride) 5 mg oral capsule |
| Terbinafine hydrochloride 1% gel |
Terbinafine (as terbinafine hydrochloride) 10 mg/g cutaneous gel |
| Terbutaline sulfate 0.2mg/inh aerosol |
Terbutaline sulfate 200 microgram/mL solution for inhalation |
| Terbutaline sulfate 200mg/20mL nebulizer solution |
Terbutaline sulfate 10 mg/mL solution for inhalation |
| Terbutaline sulfate 5mg/2mL nebulization unit |
Terbutaline sulfate 2.5 mg/mL solution for inhalation |
| Terlipressin 1mg powder and solvent for injection solution vial |
Terlipressin only product |
| Terlipressin 1mg powder for conventional release solution for injection vial |
Terlipressin only product |
| Termination of pregnancy |
Induced termination of pregnancy (procedure) |
| Termination of pregnancy operation NOS |
Operative termination of pregnancy |
| Termination of pregnancy operation NOS |
Operative termination of pregnancy |
| Terodiline hydrochloride adverse reaction |
Adverse reaction to terodiline (disorder) |
| Terrestrial mollusk - dietary |
Terrestrial mollusk (substance) |
| Testicular feminization |
Androgen resistance syndrome |
| Testicular hypogonadism |
Male hypogonadism |
| Testicular sperm aspiration |
Aspiration of seminal fluid from testis (procedure) |
| Testis TNM finding |
American Joint Committee on Cancer allowable value |
| Testosterone 1% gel |
Testosterone only product |
| Testosterone 30mg buccal system |
Testosterone 30 mg buccal film |
| Testosterone 50mg gel 5g sachet |
Testosterone 10 mg/g cutaneous gel |
| Testosterone cypionate 100mg/mL injection solution ampule |
Product containing only testosterone in parenteral dose form (medicinal product form) |
| Testosterone cypionate 200mg/cc |
Product containing only testosterone in parenteral dose form (medicinal product form) |
| Testosterone cypionate 200mg/mL |
Product containing only testosterone in parenteral dose form (medicinal product form) |
| Testosterone cypionate 200mg/mL injection solution ampule |
Product containing only testosterone in parenteral dose form (medicinal product form) |
| Testosterone implant |
Testosterone-containing product in parenteral dose form |
| Testosterone implant allergy |
Allergy to testosterone |
| Testosterone patch allergy |
Allergy to testosterone |
| Tetanus and low dose diphtheria double vaccination |
Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure) |
| Tetanus and low dose diphtheria double vaccination |
Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure) |
| Tetanus and low dose diphtheria double vaccination |
Administration of vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (procedure) |
| Tetanus immunization |
Administration of tetanus vaccine |
| Tetracaine hydrochloride 0.3%/dextrose 6% injection solution |
Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tetracaine hydrochloride 1% injection solution vial |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tetracaine hydrochloride 10mg/mL |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tetracaine hydrochloride 3mg/mL |
Product containing precisely tetracaine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Tetracycline 125mg/5mL mixture |
Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Tetracycline 125mg/5mL syrup |
Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Tetracycline group overdose |
Tetracycline antibacterial overdose (disorder) |
| Tetracycline hydrochloride 1% ointment |
Tetracycline 10 mg/g cutaneous ointment |
| Tetracycline hydrochloride 1%wv suspension |
Tetracycline 10 mg/mL cutaneous lotion |
| Tetracycline hydrochloride allergy |
Allergy to tetracycline (finding) |
| Tetrahydrozoline hydrochloride 0.05% nasal drops |
Tetryzoline hydrochloride 500 microgram/mL nasal solution |
| Tetrahydrozoline hydrochloride 0.1% spray |
Product containing only tetryzoline (medicinal product) |
| Textured surface unstructured silicone gel-filled breast implant |
Silicone gel-filled textured breast implant (physical object) |
| Thecoma, no International Classification of Diseases for Oncology subtype |
Benign thecoma (morphologic abnormality) |
| Theobaldia |
Culiseta |
| Theophylline 100mg m/r capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 100mg prolonged-release oral capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 130mg m/r capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 130mg prolonged-release oral capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 260mg m/r capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 260mg prolonged-release oral capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 500mg m/r tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 500mg prolonged-release oral tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 50mg capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 50mg m/r capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 50mg prolonged-release oral capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 65mg m/r capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 65mg prolonged-release oral capsule |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline 80mg/15mL |
Theophylline 5.33 mg/mL oral solution |
| Theophylline 80mg/15mL elixir |
Theophylline 5.33 mg/mL oral solution |
| Theophylline anhydrous 300mg m/r tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline anhydrous 300mg prolonged-release oral tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline anhydrous 450mg m/r tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline anhydrous 450mg prolonged-release oral tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 100mg m/r tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 100mg prolonged-release oral tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 100mg tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 600mg m/r tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 600mg prolonged-release oral tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 600mg tablet |
Product containing only theophylline in oral dose form (medicinal product form) |
| Theophylline, anhydrous 80mg/15mL syrup |
Theophylline 5.33 mg/mL oral solution |
| Therapeutic apheresis |
Apheresis |
| Therapeutic apical closure |
Insertion of non-setting calcium hydroxide paste to root canal of tooth (procedure) |
FHIR